AtheroTalk

Prof. Dagmar Kratky is often called the “queen of lipid hydrolases” — and in this episode of AtheroTalk, she shares her passion for this fascinating field. Discover how cells store and mobilize fat, why maintaining the balance between these processes is essential for metabolic health, and which lipid hydrolases still remain to be discovered. Beyond the science, Dagmar Kratky also shares personal i...

What does it take to turn scientific evidence into healthcare policy that improves lives? In this AtheroTalk episode, we sit down with Prof. Zanfina Ademi, a leading health economist at Monash University, to explore how health economics shapes modern cardiovascular prevention. From the development of Productivity-Adjusted Life Years (PALYs) to the global push for lipoprotein(a) testing, Prof. Adem...

This episode of AtheroTalk features Prof. Raul Santos from Brazil, reflecting on his journey in cardiovascular medicine and his impact on the field of lipidology. The discussion covers advances in familial hypercholesterolemia, LDL lowering, and emerging therapies like Lp(a), alongside the real-world challenges of prevention across different regions. Combining scientific insight with personal pers...

What does it take to build a career at the intersection of clinical care, research, and global collaboration? In this episode of AtheroTalk, we speak with Prof. Pablo Corral from Argentina, who brings a grounded and insightful perspective on lipid disorders, cardiovascular prevention, and the evolving role of large-scale clinical trials. From tackling familial hypercholesterolemia to addressing re...

In this episode, Prof. Rory Collins shares the personal moments that shaped his career and pulls back the curtain on UK Biobank: how it really works, the tough calls, and the surprises along the way. As more of us rely on UKB for our research, this candid conversation is a must-listen for anyone using the resource: the context, trade-offs, and behind-the-scenes details you don’t usually get. -----...

This interview features Magdalena Daccord, CEO of FH Europe Foundation, discussing key challenges and future directions in the management of familial hypercholesterolemia (FH). The conversation focuses on patient advocacy, early diagnosis, and the importance of international collaboration between clinicians, researchers, and policymakers. Special attention is given to emerging initiatives, includi...

In this episode of AtheroTalk, we are honored to host Prof. John J.P. Kastelein, one of the most influential figures in lipidology and cardiovascular prevention. With a career spanning decades of groundbreaking research and innovation, Prof. Kastelein shares his personal journey and reflects on the evolution of lipid-lowering therapy — from the early days of statins to today’s rapidly expanding pi...

In this special global episode of AtheroTalk, the EAS Young Fellows move beyond their traditionally Europe-focused conversations to connect with Professor Rodrigo Alonso Karlezi in Chile, bringing a Latin American perspective to cardiovascular science. The discussion explores international advances in familial hypercholesterolaemia, and the power of international collaboration, while also addressi...

In this episode of AtheroTalk, we discuss with Prof. Gerald F. Watts, a leading world expert in the field of Familial Hypercholesterolemia (FH) and Cardio-metabolic Medicine, about his professional journey, about national strategies and policies in FH and about how can young professionals achieve a successful career. Prof. Watts shares his insights about the process of adding clinical meaning into...

Our guest, Prof. Göran K. Hansson, has spent a lifetime advancing cardiovascular science while helping steward one of the world’s most prestigious scientific institutions. His work as a Professor at Karolinska Institutet and former Secretary General of the Royal Swedish Academy of Sciences, bridges discovery, leadership, and recognition. He reflects on his clinical and academic journey and opens a...

In this episode of AtheroTalk, we talk with Prof. Ruth Frikke-Schmidt, a clinician and cardiovascular researcher, about curiosity, purpose, and growing into a life in science. She shares insights from her work on cardiovascular disease and genetics, and offers honest reflections on mentorship, setbacks, and balancing research with clinical work. It’s an inspiring listen for students and early-care...

In this AtheroTalk episode, Prof. Frederick Raal - a distinguished Professor at the University of the Witwatersrand and one of the world’s leading experts in familial hypercholesterolemia - shares insights from his clinical and research journey. He discusses balancing clinical duties with leading one of the largest HoFH cohorts globally, highlighting the importance of mentorship, curiosity, and di...

In this episode of AtheroTalk, Prof. Ron Blankstein, a leading expert in cardiovascular imaging and prevention, discusses his professional journey, the power of coronary artery calcium scoring, innovations in cardiac CT, and the future of cardiovascular risk prediction. --------------------------------------------------- Script-prep: Tatyana Storozhenko Interviewer: Tatyana Storozhenko

In this episode of the AtheroTalk, we speak with Dr Rohan Khera from the Yale School of Medicine - a leading expert in big data and artificial intelligence, and their applications in cardiovascular medicine. Are you curious about digital phenotyping? Do you want to know which AI-powered tools are already in use or soon will be in clinical practice? Did you know that a simple ECG recording can reve...

This episode explores the 2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias, highlighting key changes in cardiovascular risk assessment, LDL-C targets, Lp(a) interpretation, and lipid-lowering strategies. Listeners gain practical insights into how these updates impact everyday clinical decision-making and the future of dyslipidaemia management. ---------------...

We sit down with Prof. Bart van de Sluis, Professor of Molecular Genetics and Translational Biology at the University of Groningen (UMCG). His research unravels the molecular mechanisms that control lipid metabolism and endo-lysosomal cholesterol transport, key processes in cardiometabolic diseases such as fatty liver disease and atherosclerosis. Prof. van de Sluis leads a research group dedicated...

This time, we interview Prof. Michael Shapiro, President of the American Association of Preventive Cardiology and Chair-Elect of the AHA Council on Lipidology, Lipoprotein, Metabolism & Thrombosis. We delve into his academic journey and explore his predictions for the future of our field. --------------------------------------------------- Script-prep: Azin Kheirkhah, Svetlana Stoica, Tatyana...

Tune in to this special FH Awareness Week episode of our podcast featuring Prof. Steve Humphries. In this conversation, he shares valuable insights into familial hypercholesterolaemia (FH) and introduces the newly established EAS Paediatric Lipid Working Group. He highlights the importance of early detection, collaboration, and awareness to improve care and outcomes for children living with inheri...

Rates of obesity and related metabolic disorders have risen dramatically worldwide, yet most treatment strategies still focus on individual conditions, missing the bigger picture. A new Consensus Statement from the European Atherosclerosis Society introduces a holistic, clinically actionable framework that reflects disease progression across three stages, from early metabolic changes to advanced o...

In this episode, our guest is Dr Simon Pfisterer, group leader at the University of Helsinki and Chief Scientific Officer of Moncyte Ltd. His work bridges cutting-edge research and clinical application in dyslipidaemia and cardiovascular disease. We're talking about his academic journey, his move into biotech, and his vision for the future of precision medicine in atherosclerosis. ------------...

In this episode, a leading interventional cardiologist and pioneering researcher, Prof. Gemma Figtree brings a unique perspective at the intersection of clinical care, molecular science, and national health strategy. From her early academic journey to groundbreaking work, Prof. Figtree shares ideas that are as inspiring as they are impactful. Join us for a conversation that explores not only the s...

In this special AtheroTalk live episode from the EAS Congress floor, hosts Emiel van der Vorst and Azin Kheirkhah sit down with two leading experts and successful grant winners in cardiovascular research—Prof. Judith Sluimer, recipient of the prestigious Vici grant from the Dutch Research Council (NWO), and Prof. Keith Channon, honored with the British Heart Foundation (BHF) Research Excellence Aw...

In this episode, we talk with Prof. Noam Zelcer, a globally respected expert in the field of molecular regulation of lipid metabolism and cardiometabolic diseases. He shares his perspectives on the evolving field of lipid metabolism research. Besides his scientific insights, he encourages us to discuss our failures, which are “a feature of science, not a bug”. Another key message: “Define clear go...

How do you build confidence and momentum early in your research career? In this episode, Prof. Jeffrey Kroon shares his perspective on navigating the competitive world of academic science. From applying for grants to leading innovative research, he offers practical advice on taking bold steps forward. His key message? “Don’t hesitate - go for it!” Whether it’s your first grant application or a new...

In this episode of AtheroTalk, let's meet Prof. Børge Nordestgaard, the founder of the Copenhagen General Population Study and the current EAS President. Do you want to know more about his research trajectory, the mentors he met along the way, and the projects he's working on beyond the Copenhagen General Population Study? Or maybe you just want to get to know him more personally? Listen t...